Reference
Rasmussen ER, et al. Real-life experience with long-term prophylactic C1 inhibitor concentrate treatment of patients with hereditary angioedema: Effectiveness and cost. Annals of Allergy, Asthma and Immunology : 24 Mar 2016. Available from: URL: http://doi.org/10.1016/j.anai.2016.03.008
Rights and permissions
About this article
Cite this article
Prophylactic Cinryze costly but justified for severe HAE. PharmacoEcon Outcomes News 750, 28 (2016). https://doi.org/10.1007/s40274-016-2951-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-2951-2